Tom Fleming

Arctoris

The importance of automation and high-quality data in drug discovery

In this video, Tom Fleming, Co-Founder and COO of Arctoris, discusses the development of the start-up’s fully-automated platform, which aims to provide biotechnology companies access to high-quality and reliable drug discovery data. Fleming was awarded the ELRIG Early Careers Professional Impact Award, as sponsored by SelectScience.



LIKE 0


Tom Fleming
ELRIG

Tom Fleming

Biography

Co-Founder and COO of Arctoris More
Follow Tom

Tom Fleming

Arctoris

A chemist by background, Fleming is a cancer researcher and has experience working at leading CROs and pharmaceutical corporations. Fleming has expertise in all steps of the drug discovery process, from target identification and high-throughput screens to lead optimization.